"The US Food and Drug Administration (FDA) has approved ranibizumab injection (Lucentis, Genentech) in a prefilled syringe, the company has announced.
Like the Lucentis 0.5 mg vial, the 0.5 mg prefilled syringe (PFS) is approved"...
VIGAMOX® solution is contraindicated in patients with a history of hypersensitivity to moxifloxacin, to other quinolones, or to any of the components in this medication.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/10/2016
Additional Vigamox Information
Vigamox - User Reviews
Vigamox User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.